ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

COCP Cocrystal Pharma Inc

1.59
0.06 (3.92%)
2024年5月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Cocrystal Pharma Inc COCP NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.06 3.92% 1.59 07:31:55
始値 安値 高値 終値 前日終値
1.53 1.52 1.59 1.59 1.53
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0121:00GLOBEEnrollment Completed in Phase 2a Study with Cocrystal..
2024/3/2821:00GLOBECocrystal Pharma Reports 2023 Financial Results and Provides..
2024/3/1921:00GLOBECocrystal Pharma Receives Pre-IND Responses from the FDA on..
2024/3/0206:15EDGAR2Form 8-K - Current report
2024/1/0822:00EDGAR2Form 8-K - Current report
2024/1/0506:01EDGAR2Form 8-K - Current report
2024/1/0422:00GLOBECocrystal Pharma Provides an Update on the Clinical..
2024/1/0223:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/12/2207:00EDGAR2Form 8-K - Current report
2023/12/0622:00EDGAR2Form 8-K - Current report
2023/12/0622:00GLOBECocrystal Pharma Announces First-Patient-In for Phase 2a..
2023/12/0422:00EDGAR2Form 8-K - Current report
2023/11/2922:00EDGAR2Form 8-K - Current report
2023/11/2922:00GLOBECocrystal Pharma Highlights its Novel Inhaled and Oral..
2023/11/2722:00GLOBECocrystal Pharma to Present at the NobleCon 19 Conference on..
2023/11/1322:15EDGAR2Form 8-K - Current report
2023/11/1322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1322:00GLOBECocrystal Pharma Reports Third Quarter 2023 Financial..
2023/11/0922:00GLOBECocrystal Pharma to Discuss Progress with Novel Inhaled and..
2023/10/3121:00EDGAR2Form 8-K - Current report
2023/10/3121:00GLOBECocrystal Pharma Receives UK MHRA Authorization to Initiate..
2023/9/2821:00GLOBECocrystal Pharma Doses First Subjects in Clinical Study of..
2023/9/0521:00GLOBECocrystal Pharma to Participate in the H.C. Wainwright..
2023/8/1705:05EDGAR2Form 8-K - Current report
2023/8/1421:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1421:00GLOBECocrystal Pharma Reports Second Quarter 2023 Financial..
2023/8/0821:00GLOBECocrystal Pharma Selects Novel Oral Protease Inhibitor..
2023/7/2105:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2105:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2105:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2105:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/5/3121:00GLOBECocrystal Pharma Receives HREC Approval to Initiate Phase 1..
2023/5/1521:00GLOBECocrystal Pharma Reports First Quarter 2023 Financial..
2023/5/0505:05GLOBECocrystal Pharma Presents New Data from its CC-42344 Phase 1..

最近閲覧した銘柄

Delayed Upgrade Clock